Concepedia

Feng Xu

FX

Statistics

Publications

24

Citations

1.1K

H-Index

19

Active since

2005

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Second Military Medical University

Zhengzhou University

Henan University Huaihe Hospital and Huaihe Clinical Institute

Feng Xu is an author at First Affiliated Hospital of Zhengzhou University specializing in molecular oncology, oncology, and medicine.

Publications per year

2005–2024

24

Publications

24

LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53

Jingjing Lu, Feng Xu, Hong Lu · Life Sciences · 2020 · 295 citations

Life Sciences, Genetics, Molecular Biology +14

RETRACTED: Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a

Feng Xu, Qi Li, Zhiyu Wang et al. · Biomedicine & Pharmacotherapy · 2019 · 83 citations · Full text

Medicine, Biomedical Sciences, Oncology +7

MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma

Yan Wang, Weijia Li, Xiangyu Chen et al. · Biomedicine & Pharmacotherapy · 2019 · 74 citations · Full text

Medicine, Cancer Biology, Oncology +17

TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer

Xiaochun Liu, Jing Ma, Feng Xu et al. · Biomedicine & Pharmacotherapy · 2018 · 66 citations

Medicine, Molecular Biology, Oncology +14

miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9.

Yajun Zhang, Feng Xu, Yijie Zhang et al. · PubMed · 2015 · 49 citations

Medicine, Molecular Biology, Oncology +17

1–5 of 24